Multi-modal imaging of high-risk ductal carcinoma in situ of the breast using C2Am: a targeted cell death imaging agent.

Zoltan SzucsJames JosephTim J LarkinBangwen XieSarah E BohndiekKevin M BrindleAndré A Neves

Published in: Breast cancer research : BCR (2021)

C2Am is a targeted multi-modal imaging agent that could complement current anatomical imaging methods for detecting DCIS. Imaging the presence and spatial extent of necrosis may give better prognostic information than that obtained by biopsy alone.

Keyphrases

high resolution
cell death
fluorescence imaging
drug delivery
cancer therapy
photodynamic therapy
health information
cell cycle arrest